SCHEMBL5087381

SCHEMBL5087381

CCOC(=O)Nc1ccc(OCc2ccccc2C(F)(F)F)cc1N

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 4/20 0.51
MAOA P21397 1/20 0.51
HPGD P15428 1/20 0.46
KDM4E B2RXH2 1/20 0.46
KMT2A Q03164 1/20 0.46
KCNQ2 O43526 3/20 0.44
KCNQ3 O43525 2/20 0.44
KCNQ4 P56696 1/20 0.44
KCNQ5 Q9NR82 1/20 0.44
CYP1A2 P05177 3/20 0.44
CYP2C19 P33261 3/20 0.44
CYP3A4 P08684 2/20 0.44
CYP2D6 P10635 1/20 0.44
SPHK2 Q9NRA0 3/20 0.43
SPHK1 Q9NYA1 3/20 0.43
CYP2C9 P11712 2/20 0.41
FFAR1 O14842 1/20 0.41
FFAR4 Q5NUL3 1/20 0.41
ADAMTS4 O75173 1/20 0.41
MMP13 P45452 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5089271 0.87 PARP10 (0.50) MAOBKDM4EKCNQ2KCNQ3KCNQ4
SCHEMBL5090936 0.86 MAOB (0.48) MAOBHPGDKMT2AKCNQ2KCNQ3
SCHEMBL5087356 0.86 KCNQ2 (0.45) KMT2AKCNQ2KCNQ3KCNQ4KCNQ5
SCHEMBL5090320 0.81 ALDH1A1 (0.53) MAOBHPGDKMT2AKCNQ2KCNQ3
SCHEMBL5087380 0.81 KCNQ2 (0.57) MAOBKMT2AKCNQ2KCNQ3KCNQ4
SCHEMBL5087179 0.80 MAOB (0.54) MAOBKCNQ2KCNQ3FFAR1FFAR4
SCHEMBL5096507 0.80 KCNQ2 (0.54) MAOBHPGDKDM4EKMT2AKCNQ2
SCHEMBL14097681 0.79 CYP1A2 (0.56) HPGDKCNQ2KCNQ3KCNQ4KCNQ5
SCHEMBL5095903 0.78 KCNQ2 (0.47) MAOBHPGDKDM4EKMT2AKCNQ2
SCHEMBL5090219 0.78 KCNQ2 (0.44) MAOBKMT2AKCNQ2KCNQ3KCNQ4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080188561-A1 N-[2-AMINO-4-(PHENYLMETHOXY)PHENYL] AMIDES AND RELATED COMPOUNDS AS POTASSIUM CHANNEL MODULATORS JPMORGAN CHASE BANK, N.A. 2008-08-07 US claimed
US-8722929-B2 N-[2-amino-4-(phenylmethoxy)phenyl] amides and related compounds as potassium channel modulators VALEANT PHARMACEUTICALS INTERNATIONAL (US) 2014-05-13 US disclosed
US-20080188561-A1 N-[2-AMINO-4-(PHENYLMETHOXY)PHENYL] AMIDES AND RELATED COMPOUNDS AS POTASSIUM CHANNEL MODULATORS JPMORGAN CHASE BANK, N.A. 2008-08-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080188561-A1 N-[2-AMINO-4-(PHENYLMETHOXY)PHENYL] AMIDES AND RELATED COMPOUNDS AS POTASSIUM CHANNEL MODULATORS KCNB2, KCNJ2, KCNA2 MAOB 808/4885MAOA 1086/4885HPGD 2285/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.